The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline PSMA PET/CT as a predictive biomarker for toxicity and patient-reported outcomes in mCRPC patients undergoing 177Lu-PSMA radioligand therapy.
 
Vishnu Murthy
No Relationships to Disclose
 
Ojaswita Lokre
Employment - AIQ Solutions
 
Timothy G. Perk
Employment - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Patents, Royalties, Other Intellectual Property - Apparatus for Monitoring Treatment Side Effects (patent pending) Healthy organ systems are monitored over time and used to identify adverse events in those organs.; ASSESSMENT OF DISEASE TREATMENT (patent pending) This system takes in various imaging metrics and can provide an estimate of how effective a treatment has been for a specific patient, i.e. is a patient going to have a short or a long benefit from the curr; Image Enhancement System for Bone Disease Evaluation A standardized skeleton template is used to normalize medical image data of the skeleton to eliminate variations in the medical image data related to physiological variations in a normal patient thereby; System and Method for Monitoring Multiple Lesions (patent pending) The system uses registration and optimization to accurately determine which lesions are the same between multiple imaging timepoints.
 
Lucia Chen
No Relationships to Disclose
 
Pan Thin
No Relationships to Disclose
 
Kathleen Nguyen
No Relationships to Disclose
 
Stephanie Lira
No Relationships to Disclose
 
Rejah M. Alano
No Relationships to Disclose
 
Andrei Gafita
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Aktis Oncology; Amgen; Jubilant Radiopharma; POINT Biopharma; RayzeBio
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics